Comparison Between Effect of Vitamin D Versus Dexmedetomidine in Patients with Head Trauma Using Interleukin 6
NCT ID: NCT06565338
Last Updated: 2024-11-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2021-04-25
2024-02-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dexmedetomidine on Brain Injury Patients
NCT06661980
Neuroprotective Effect of Dexomitomidine
NCT05487742
Dexanabinol in Severe Traumatic Brain Injury
NCT00129857
Ketogenic Diet for Traumatic Brain Injury
NCT03982602
Scalp Block Versus Scalp Infiltration With Dexmedetomidine and Local Anesthetic for Post Craniotomy Pain
NCT02866409
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group A
dexmedetomidine 0.4 mic/kg loading dose then 0.25 mic/kg/hr for 5 days
Dexmedetomidine
drug
group B
vitamin D 100.000 IU given IM once
Vitamin D3
drug
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexmedetomidine
drug
Vitamin D3
drug
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age (18-50)
* GCS (8-12)
* Pt with traumatic brain insult who not indicated surgical intervention
Exclusion Criteria
* Isolated brain system lesions.
* History of underlying neurologic, metabolic or psychiatric disorders.
* Alcohol or drug abuse.
* Pregnancy.
* Patients with intracranial hemorrhage who indicated surgical evacuation.
* Multisystem life-threatening trauma.
* GCS \> 12 \& \<8.
* Vitamin d deficiency.
18 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Minia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
asmaa elhelw
Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ahmed ezz
Role: STUDY_CHAIR
Minia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Asmaa
Minya, Minya Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
403
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.